Anthony Abbruscato Email

VP, Clinical Development . Stealth BioTherapeutics

Current Roles

Employees:
77
Revenue:
$9.3M
About
Our Mission Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Our team works with patients and advocacy organizations to better understand their journey and raise awareness of the unmet need our programs seek to address. We collaborate with top-tier academic and medical institutions, scientific thought leaders, and clinical key opinion leaders in developing the first generation of targeted therapies focusing on mitochondrial dysfunction as it presents in these rare genetic diseases and common diseases of aging. With these collaborative efforts, we continue to advance our platform of late-stage clinical programs and novel pipeline candidates.
Stealth BioTherapeutics Address
140 Kendrick Street
Newton, MA
United States
Stealth BioTherapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.